SEC Form 4 · accession 0001140361-17-021237
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Baffi
Officer — EVP, Technical Operations
Period of report
Apr 28, 2017
Accepted (ET)
May 17, 2017 · 6:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 28, 2017 | A | 302 | $70.304 | A | 147,793 | D | |
| Common Stock | May 15, 2017 | F | 1,566 | $91.50 | D | 146,227 | D | |
| Common Stock | holding | — | — | — | 31,676 | I | Shares held by Baffi Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares acquired by the reporting person pursuant to issuer's Employee Stock Purchase Plan.